Low-Dose Radiation Therapy for Hand Osteoarthritis
Hand osteoarthritis is where the LDRT evidence is most mixed. Prospective series report meaningful benefit; the one published randomized trial found no significant effect at 3 months.
Evidence
Donaubauer et al.: 483 patients retrospective; 70% pain improvement at 3 months (short follow-up).
Alvarez et al.: 100 patients prospective; VAS 8 → 4/3/3.5 at 3/6/12 months; 70% functional improvement; no toxicity.
Rogers et al.: 99 patients prospective; pain relief and grip strength improvement by dynamometer.
Minten et al. 2018 (RCT, null): 56 patients randomized; 31% responders (LDRT) vs 27% (control) — not significant. ARS AUC limitations: small sample, 3-month follow-up only, 1 Gy/fraction vs standard 0.5 Gy.
Clinical note: if DIP joints are involved, nail bed shielding may cause inadequate coverage of the treatment target — discuss this tradeoff with your radiation oncologist.
Turning down inflammation in an arthritic hand
01 - Inflamed hand - Reactive joint linings: Small joints, including the finger joints and the thumb base, can develop thickened, reactive linings that amplify pain.
02 - During treatment - Local signaling shifts: Small doses aim to change immune-cell and endothelial behavior, not destroy the joint.
03 - The weeks after - Quieter joint linings: The linings may become less reactive and send fewer pain signals over 4 to 12 weeks.
What changes: inflammatory behavior. What does not: bone, cartilage, and joint alignment are not rebuilt.
Medically reviewed by:Robert Warren Floyd, M.D., Ph.D. — Resident Physician, Radiation Oncology, The University of Texas MD Anderson Cancer Center. Last reviewed: September 8, 2026. Independent personal project — not affiliated with or endorsed by MD Anderson Cancer Center. Funding & independence disclosure.
This content is for education only and is not medical advice. Always consult a qualified healthcare provider for diagnosis and treatment decisions.